During the past decade, Orthopaedic Hemophilia Treatment Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orthopaedic Hemophilia Treatment Center" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Hemophilia of Georgia, Inc." with 1 trials as a collaborator, "Laboratoire français de Fractionnement et de Biotechnologies" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Orthopaedic Hemophilia Treatment Center" are "Hemophilia A" (3 trials), "Hemophilia B" (3 trials), "Bleeding Disorder" (1 trials), "Connective Tissue Disorder" (1 trials) and "Haemophilia A Without Inhibitor" (1 trials). Many other conditions were trialed in "Orthopaedic Hemophilia Treatment Center" in a lesser frequency.

Most popular intervention types in "Orthopaedic Hemophilia Treatment Center" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AskBio009" (1 trials), "BAX 888" (1 trials), "Coagulation Factor VIIa (Recombinant)" (1 trials), "MOD-5014" (1 trials) and "Non-treatment, seroprevalence" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orthopaedic Hemophilia Treatment Center" are 5 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Orthopaedic Hemophilia Treatment Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Orthopaedic Hemophilia Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orthopaedic Hemophilia Treatment Center, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".